The Latest Breaking News from Horizon

Data also used for planning, analytics and measurement

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration’s push for lower drug prices at the pharmacy counter.

Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics

The FTC plans to block Amgen's takeover of Horizon. The move reverberated across biotechs, with an HZNP stock crash leading the way.

Stock futures slip lower with debt ceiling talks in focus; Retail sales on deck after consumers powered Q1 GDP growth; Home Depot earnings in focus as retail week heats up; Warren Buffett's Berkshire Hathaway takes new position in Capital One and Horizon Therapeutics plunges on report FTC will sue to…

Post Office Limited’s former head of product and branch accounting gave evidence to the Horizon inquiry on Thursday.

The Horizon series has shipped more than 32 million copies, and it's not done yet

As Kevin Costner heads for divorce, his to-be-ex's rumored threats about Yellowstone from months past have resurfaced.

The Post Office authorised the payments based on a target executives had set themselves.